| scholarly article | Q13442814 |
| P8150 | COVIDWHO ID | covidwho-14064 |
| P6179 | Dimensions Publication ID | 1125838011 |
| P356 | DOI | 10.1016/J.AUTREV.2020.102524 |
| P932 | PMC publication ID | 7271072 |
| P698 | PubMed publication ID | 32220633 |
| P8299 | Semantic Scholar corpus ID | 214694867 |
| P50 | author | Roberto Giacomelli | Q42416418 |
| Piero Ruscitti | Q88511212 | ||
| P2093 | author name string | Antonio Del Puente | |
| Luisa Costa | |||
| Raffaele Scarpa | |||
| Francesco Caso | |||
| Luca Navarini | |||
| P2860 | cites work | Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*) | Q24631660 |
| IL-6 in inflammation, immunity, and disease | Q34248105 | ||
| Adult haemophagocytic syndrome | Q38167486 | ||
| Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | Q83767469 | ||
| Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study | Q89996428 | ||
| Dysregulation of immune response in patients with COVID-19 in Wuhan, China | Q90251434 | ||
| Emergent high fatality lung disease in systemic juvenile arthritis | Q90338391 | ||
| COVID-19: consider cytokine storm syndromes and immunosuppression | Q90464964 | ||
| COVID-19 infection and rheumatoid arthritis: Faraway, so close! | Q90602641 | ||
| Interleukin-6 promotor gene polymorphisms and susceptibility to chronic hepatitis B virus in Egyptians | Q90806132 | ||
| Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors | Q92399558 | ||
| P921 | main subject | Coronaviridae | Q1134583 |
| P304 | page(s) | 102524 | |
| P577 | publication date | 2020-03-24 | |
| P1433 | published in | Autoimmunity Reviews | Q15754966 |
| P1476 | title | Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? |
| Q91598374 | ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia |
| Q96683098 | Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19 |
| Q100466510 | Benchmarking evolutionary tinkering underlying human-viral molecular mimicry shows multiple host pulmonary-arterial peptides mimicked by SARS-CoV-2 |
| Q98153597 | Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology |
| Q94588797 | How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion |
| Q94522568 | SARS-CoV-2 can induce brain and spine demyelinating lesions |
| Q96647317 | Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm |
| Q94588769 | Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions |
| Q94659054 | Spotlight for healthy adolescents and adolescents with preexisting chronic diseases during the COVID-19 pandemic |
| Q104748237 | The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature |
| Q94549302 | The correlation between SARS-CoV-2 infection and rheumatic disease |
| Q95818691 | Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) |
| Q91598362 | What is the role of rheumatologists in the era of COVID-19? |
Search more.